Gresser I
Tex Rep Biol Med. 1977;35:394-8.
The effect of interferon in animals infected with some oncogenic viruses can be attributed to inhibition of viral replication or inhibition of the early events following viral infection. In those experimental systems in which continued administration of interferon proved effective after inoculation of oncogenic viruses, the effect may be due in part to an antiviral effect and in part to a direct action of interferon on the multiplication of precursor cells or tumor cells themselves. In animals bearing autochthonous tumors or grafted with transplantable tumors, the effects appear to be due in part to a a direct inhibition of the multiplication of the tumor cell (or an effect on the behavior of these tumor cells) and in part to an effect on the host - the nature of which remains to be defined. We must learn more of the interaction of interferon with host cells and understand how so many apparently different effects are triggered by this "polypractic substance" (6) before we can clarify the mechanism by which interferon can confer protection on animals infested with viruses, protozoa, or tumor cells.
干扰素对感染某些致癌病毒的动物的作用,可归因于对病毒复制的抑制或对病毒感染后早期事件的抑制。在那些致癌病毒接种后持续给予干扰素被证明有效的实验系统中,其作用可能部分归因于抗病毒作用,部分归因于干扰素对前体细胞或肿瘤细胞自身增殖的直接作用。在患有自发性肿瘤或移植有可移植肿瘤的动物中,其作用似乎部分归因于对肿瘤细胞增殖的直接抑制(或对这些肿瘤细胞行为的影响),部分归因于对宿主的影响——其性质尚待确定。在我们能够阐明干扰素能够对感染病毒、原生动物或肿瘤细胞的动物提供保护的机制之前,我们必须更多地了解干扰素与宿主细胞的相互作用,并了解这种“多能物质”(6)是如何引发如此多明显不同的作用的。